Dr. Barry Dworkin

No hype, no promises but Oxford coronavirus vaccine research is moving ahead with larger scale human trials

Medical Mythbusting Commentary for April 28, 2020

Source:
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead

Related posts:

  1. Researchers are doing their job when clinical trials are put on hold. Data and safety monitoring are part of the process. There are no shortcuts even for the Covid-19 vaccines in development.
  2. Animal study shows promise in Hepatitis C vaccine research
  3. Adverse allergic reactions reported with Pfizer vaccine was expected. Briefing documents showed 6/1000 in treatment group and 5/1000 in placebo group had allergic reactions. Vaccine eligibility will be refined after determining the nature of the reactions
  4. Israeli study offers more evidence of Pfizer vaccine efficacy with 94% drop in symptomatic cases and 92% decrease in severe illness in people aged 55 and older.—- Restriction-easing plan in Ontario risks Yo-Yo effect once again.